CSE Bulletin: Reinstatement - Nirvana Life Sciences Inc. (NIRV)

newsfileDec 20 14:41 ET

Nirvana Raises $24.2M Series A to Revolutionize Health Insurance Verification

BusinesswireSep 12 15:33 ET

Xai Foundation Launches Nodes on Nirvana Cloud, Ushering In a New Era of Layer 3 Scalability and Cutting Edge Web3 Cloud Computing for Gaming

PR NewswireApr 30 12:30 ET

Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

newsfileJan 29 09:01 ET

Nirvana Life Sciences Inc: INTERIM MDA EN

SEDARNov 1, 2023 13:47 ET · Announcements

Nirvana Life Sciences Inc: INTERIM FINANCIAL STATEMENTSREPORT EN

SEDARNov 1, 2023 13:45 ET · Announcements